|Bid||224.0300 x 300|
|Ask||224.1300 x 100|
|Day's Range||222.4100 - 225.2400|
|52 Week Range||184.5000 - 256.8000|
|PE Ratio (TTM)||6.97|
|Dividend & Yield||2.80 (1.25%)|
|1y Target Est||N/A|
Companies included on the S&P 500 index bought back more than $500 billion in stock last year and have bought back more than $4 trillion in shares since 2008.
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Allergan Plc a score of 28. Our analysis is based on comparing Allergan Plc with the following peers – Mylan N.V., Zoetis, Inc. Class A, Merck & Co., Inc. and Abbott Laboratories (MYL-US, ZTS-US, MRK-US and ABT-US). Investment Outlook Allergan Plc has a fundamental score of 28 ... Read more (Read more...)
Shire plc (SHPG) submitted a Marketing Authorization Application (MAA) for lifitegrast for the treatment of dry eye disease in Europe.